title: CCN1 expression in interleukin-6 deficient mouse kidney in experimental model of heart failure.
abstract: Chronic heart failure often leads to worsening of the renal function. Mediators of this process include inflammatory and neuroendocrine factors. CCN1 (Cyr 61), a member of growth factor-inducible immediate early genes, which modulates inflammation and fibrogenesis, is excreted with urine in the early phase of acute renal injury and may be involved in the pathogenesis of the cardiorenal syndrome. The aim of the study was to evaluate CCN1 protein abundance and localization in the kidney of IL-6-deficient C57BL/6J (IL-6 KO) mice and respective wild-type (WT) animals in basal conditions and in animals with chronic heart failure twelve weeks after myocardial infarction. Age- and sex-matched mice from both strains subjected to sham operation served as controls. One group of WT animals subjected to myocardial infarction was treated with antagonist of AT1 receptor telmisartan over 12 weeks. Abundance and localization of CCN1 protein in kidney were assessed with Western blotting and immunohistochemistry, respectively. In all groups the strongest immunohistochemical reaction for CCN1 was observed in distal convoluted tubules and in smaller arteries, however, the total expression of CCN1 protein was lower in IL-6 KO mice in comparison to WT animals. The main difference in CCN1 distribution between the examined genotypes was lack of reaction in internal renal medulla and very weak reaction in proximal convoluted tubules in IL-6 KO mice. Experimental heart failure only slightly attenuated the expression of CCN1 protein in the kidney of WT mice and had no effect in IL-6 KO mice. Although, blockade of AT1 receptor did not alter CCN1 protein expression in kidneys of WT mice after myocardial infarction, it significantly changed its CCN1 distribution in the renal tubular system.
authors.affiliation: Department of General and Experimental Pathology, Medical University of Bialystok. patofiz@umb.edu.pl
authors.forename: Tomasz Andrzej
authors.initials: TA
authors.lastname: Bonda
authors.forename: Andrzej
authors.initials: A
authors.lastname: Taranta
authors.forename: Karol Adam
authors.initials: KA
authors.lastname: Kaminski
authors.forename: Magdalena
authors.initials: M
authors.lastname: Dziemidowicz
authors.forename: Sergey
authors.initials: S
authors.lastname: Litvinovich
authors.forename: Marcin
authors.initials: M
authors.lastname: Kozuch
authors.forename: Izabela
authors.initials: I
authors.lastname: Bialuk
authors.forename: Lech
authors.initials: L
authors.lastname: Chyczewski
authors.forename: Maria Malgorzata
authors.initials: MM
authors.lastname: Winnicka
mesh_terms: D000818:Animals; D015153:Blotting, Western; D055515:Cysteine-Rich Protein 61 / Q000378:metabolism*; D004195:Disease Models, Animal; D060005:Genotyping Techniques; D006333:Heart Failure / Q000378:metabolism* / Q000473:pathology; D007150:Immunohistochemistry; D015850:Interleukin-6 / Q000172:deficiency* / Q000378:metabolism; D007668:Kidney / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009203:Myocardial Infarction / Q000378:metabolism / Q000473:pathology
chemical_list: C491850:CCN1 protein, mouse; D055515:Cysteine-Rich Protein 61; D015850:Interleukin-6